Maravai LifeSciences Holdings, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Maravai LifeSciences Holdings, Inc. (MRVI) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $25.66 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-26
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $25.66M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $28.62M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $28.62M.
- 2025-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $28.53M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $25.66M 10-K · filed 2026-02-26 |
| 2025-09-30 | $28.62M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $28.62M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $28.53M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $27.46M 10-K · filed 2025-03-18 |
| 2024-09-30 | $27.46M 10-Q · filed 2024-11-12 |
| 2023-12-31 | $27.48M 10-K · filed 2024-02-29 |
| 2023-09-30 | $27.48M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $27.48M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $27.48M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $24.81M 10-K · filed 2023-02-28 |
| 2022-09-30 | $24.81M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $24.81M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $24.81M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $14.60M 10-K · filed 2022-03-01 |
| 2021-09-30 | $14.60M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $14.60M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $19.43M 10-Q · filed 2021-05-12 |